Get the Stockscreener App
4.14
3.72%
-0.16
Verrica Pharmaceuticals Inc stock is traded at $4.14, with a volume of 114.54K.
It is down -3.72% in the last 24 hours and down -18.02% over the past month.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
See More
Previous Close:
$4.30
Open:
$4.27
24h Volume:
114.54K
Relative Volume:
0.54
Market Cap:
$39.11M
Revenue:
$5.12M
Net Income/Loss:
$-67.00M
P/E Ratio:
-2.8163
EPS:
-1.47
Net Cash Flow:
$-38.94M
1W Performance:
-11.35%
1M Performance:
-18.02%
6M Performance:
-6.46%
1Y Performance:
-67.91%
1-Day Range:
$4.1001
$4.36
1-Week Range:
$4.0916
$4.8498
52-Week Range:
$3.816
$17.38
Verrica Pharmaceuticals Inc Stock (VRCA) Company Profile
Name
Verrica Pharmaceuticals Inc
Sector
Industry
Phone
484-453-3300
Address
10 NORTH HIGH STREET, WEST CHESTER, PA
Compare VRCA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VRCA
Verrica Pharmaceuticals Inc
|
4.14 | 40.62M | 5.12M | -67.00M | -38.94M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Verrica Pharmaceuticals Inc Stock (VRCA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-06-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Nov-05-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jul-25-23 | Upgrade | Needham | Hold → Buy |
| Mar-22-23 | Initiated | Jefferies | Buy |
| Feb-13-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-14-21 | Initiated | RBC Capital Mkts | Outperform |
| Dec-24-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-15-20 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-30-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-24-20 | Initiated | Northland Capital | Outperform |
| Mar-24-20 | Initiated | Needham | Buy |
| Feb-21-19 | Initiated | H.C. Wainwright | Buy |
View All
Verrica Pharmaceuticals Inc Stock (VRCA) Latest News
Is Verrica Pharmaceuticals Inc. stock poised for growth2025 Growth vs Value & Fast Exit Strategy with Risk Control - newser.com
Technical signs of recovery in Verrica Pharmaceuticals Inc.Quarterly Market Summary & Risk Controlled Daily Trade Plans - newser.com
How to recover losses in Verrica Pharmaceuticals Inc. stockJuly 2025 Momentum & Consistent Profit Alerts - newser.com
Published on: 2025-10-10 09:59:41 - newser.com
Is this a good reentry point in Verrica Pharmaceuticals Inc.2025 Price Targets & Expert Curated Trade Setup Alerts - newser.com
Published on: 2025-10-09 06:44:03 - newser.com
Will Verrica Pharmaceuticals Inc. stock rally after Fed decisionsJuly 2025 Short Interest & Smart Money Movement Alerts - newser.com
Smart tools for monitoring Verrica Pharmaceuticals Inc.’s price action2025 Market Trends & Low Risk High Win Rate Stock Picks - newser.com
What analysts say about Verrica Pharmaceuticals Inc stockMarket Breadth Indicators & High Return Portfolio Growth - earlytimes.in
Verrica Pharmaceuticals to Present New Data on VP-315 from - GlobeNewswire
12‑Week Immune Activation: Verrica Presents Phase 2 VP-315 Tumor Microenvironment Data at SITC - Stock Titan
What drives Verrica Pharmaceuticals Inc stock priceResistance Zone Identification & Machine Learning Stock Picks, Daily - earlytimes.in
Why analysts raise outlook for Verrica Pharmaceuticals Inc. (1NE) stockGap Up & Risk Adjusted Swing Trade Ideas - newser.com
Is Verrica Pharmaceuticals Inc. stock positioned for digital transformation2025 Year in Review & Risk Controlled Swing Trade Alerts - newser.com
What drives Verrica Pharmaceuticals Inc 1NE stock priceDouble Top/Bottom Patterns & Superior Capital Trading Plans - earlytimes.in
Published on: 2025-10-05 07:16:48 - newser.com
What makes Verrica Pharmaceuticals Inc. (1NE) stock appealing to growth investorsRate Cut & Weekly High Potential Stock Alerts - newser.com
Risk adjusted return profile for Verrica Pharmaceuticals Inc. analyzed2025 Analyst Calls & Real-Time Chart Breakout Alerts - newser.com
News impact scoring models applied to Verrica Pharmaceuticals Inc.July 2025 Drop Watch & Long Hold Capital Preservation Tips - newser.com
Using data tools to time your Verrica Pharmaceuticals Inc. exitJuly 2025 Trade Ideas & Long-Term Growth Portfolio Plans - newser.com
Will Verrica Pharmaceuticals Inc. (1NE) stock justify high valuationJuly 2025 Catalysts & Safe Capital Investment Plans - newser.com
Why Verrica Pharmaceuticals Inc. (1NE) stock stays on top picksQuarterly Trade Review & Consistent Income Trade Ideas - newser.com
Is Verrica Pharmaceuticals (NASDAQ:VRCA) Weighed On By Its Debt Load? - 富途牛牛
What technical models suggest about Verrica Pharmaceuticals Inc.’s comebackJuly 2025 Summary & Low Risk High Reward Ideas - newser.com
How to build a dashboard for Verrica Pharmaceuticals Inc. stock2025 AllTime Highs & Reliable Intraday Trade Alerts - newser.com
Does Verrica Pharmaceuticals Inc. fit your quant trading modelRecession Risk & Weekly Chart Analysis and Guides - newser.com
Is Verrica Pharmaceuticals Inc. (1NE) stock a safe buy pre earningsMarket Trend Report & Weekly High Conviction Trade Ideas - newser.com
Earnings visualization tools for Verrica Pharmaceuticals Inc.July 2025 Catalysts & Free Safe Entry Trade Signal Reports - newser.com
Goldman Sachs Group Inc. Boosts Stake in Verrica Pharmaceuticals Inc. $VRCA - Defense World
Published on: 2025-10-01 07:41:33 - newser.com
Why Verrica Pharmaceuticals Inc. (1NE) stock remains top ratedJuly 2025 Chart Watch & Weekly Watchlist for Hot Stocks - newser.com
Verrica Pharmaceuticals Inc Stock (VRCA) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):